Australian firms set up one-stop shop for prescriptions and e-liquid

Two Australian vaping businesses have found a way to integrate Australia’s tricky regulatory scheme into their business.

Under Australian law, nicotine is treated as a poison, following the Commonwealth Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) and most Australian businesses cannot stock nicotine e-liquid.

For an Australian resident to acquire e-liquid with nicotine they must first get a medical certificate. They can then only import a limited supply from overseas or get it made from an accredited compound pharmacy locally.

But now the companies Nicopharm and Nicovape have developed a process where people can get the prescription and the e-liquid in one transaction.

First the customer fills in an online questionnaire and after the assessment within 24 hours by an affiliated doctor, they can order the product.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization